The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.
Artificial Intelligence: The Future of Regulatory Affairs
Linda Bowen, MSc, RAC
Head of Regulatory Policy and Intelligence
Seattle Genetics, United States
This session will focus on the various aspects of artificial intelligence (AI) currently incorporated in regulatory processes as well a futuristic look at what it can do for the RA function. Case studies and lessons learned on AI pilots within the biopharma and medical device industry will be highlighted as well as FDA's perspective on the future of AI.
Learning Objective : Formulate a strategy for a future regulatory affairs function that leverages the use of advanced technologies
Design a holistic regulatory information management operating model (governance, people, process, and traditional and advanced technology)
Regulatory 2.0: The Future of Regulatory Affairs and Advanced Technologies
Deloitte, United States
Exploring New Ways of Working Using Artificial Intelligence: Proof of Concept Pilot